Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

By: IPP Bureau

Last updated : August 03, 2023 11:36 am



The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023


Jagsonpal Pharmaceuticals Limited has reported Standalone financial results for the period ended June 30, 2023.

The company has posted net profit of Rs. 7.47 crores for the period ended June 30, 2023 as against net profit of Rs. 5.60 crores for the period ended March 31, 2023. It posted net profit of Rs.2.92 crores for the period ended June 30, 2022.

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023 as compared to Rs. 58.01 crores during the period ended March 31, 2023. It reported total income of Rs.60.91 crores during the period ended June 30, 2022.

Jagsonpal Pharmaceuticals

First Published : August 03, 2023 12:00 am